Clinical Scorecard: Correction to: The Count of Tumor Deposits as a Standalone Prognostic Indicator in Colorectal Cancer—Findings from a Population-Based Cohort Analysis
At a Glance
Category
Detail
Condition
Colorectal cancer
Key Mechanisms
Tumor deposit (TD) count as an independent prognostic factor
Target Population
Patients with colorectal cancer
Care Setting
Population-based cohort study context
Key Highlights
Both TD-positive and TD-negative tumors are more commonly located in the left colon than the right.
Right-sided tumors are relatively more frequent among TD-positive patients compared to TD-negative patients.
Tumor location was included as a variable in regression analysis, ensuring results were unaffected by location ambiguity.
Guideline-Based Recommendations
Diagnosis
Consider tumor deposit count in prognostic assessment of colorectal cancer.
Management
Incorporate tumor location and TD status in clinical decision-making.
Monitoring & Follow-up
Monitor tumor deposit status as part of patient follow-up.
Risks
Be aware of tumor location distribution differences between TD-positive and TD-negative cases.
Patient & Prescribing Data
Colorectal cancer patients with varying tumor deposit status
Tumor deposit count and tumor location should be considered in prognosis and treatment planning.
Clinical Best Practices
Accurately document tumor deposit status and tumor location in pathology reports.
Use regression models including tumor location to assess prognostic impact of tumor deposits.
Clarify ambiguous data presentation to avoid misinterpretation of tumor distribution.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
